Literature DB >> 31168911

Asymmetric Total Synthesis of (+)-Neooxazolomycin Using a Chirality-Transfer Strategy.

Jae Hyun Kim1, Illan Kim1, Yeonghun Song1, Min Jung Kim1, Sanghee Kim1.   

Abstract

The total synthesis of (+)-neooxazolomycin was achieved from the amino-acid d-serine. The efficiency of this approach is derived from the use of principles of memory of chirality and dynamic kinetic resolution in the intramolecular aldol reaction of a serine derivative to build the densely functionalized lactam framework and to install three contiguous stereocenters. The key intermediate was readily elaborated to the target natural product.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alkaloids; asymmetric synthesis; diastereoselectivity; natural products; total synthesis

Year:  2019        PMID: 31168911     DOI: 10.1002/anie.201906158

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  4 in total

1.  Oxodealkenylative Cleavage of Alkene C(sp3 )-C(sp2 ) Bonds: A Practical Method for Introducing Carbonyls into Chiral Pool Materials.

Authors:  Andrew J Smaligo; Jason Wu; Nikolas R Burton; Allison S Hacker; Aslam C Shaikh; Jason C Quintana; Ruoxi Wang; Changmin Xie; Ohyun Kwon
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-02       Impact factor: 15.336

Review 2.  Acyclic Twisted Amides.

Authors:  Guangrong Meng; Jin Zhang; Michal Szostak
Journal:  Chem Rev       Date:  2021-08-18       Impact factor: 72.087

3.  Enantioselective Michael-Proton Transfer-Lactamization for Pyroglutamic Acid Derivatives: Synthesis of Dimethyl-(S,E)-5-oxo-3-styryl-1-tosylpyrrolidine-2,2-dicarboxylate.

Authors:  Christian M Chaheine; Conner J Song; Paul T Gladen; Daniel Romo
Journal:  Organic Synth       Date:  2021

Review 4.  The oxazolomycin family: a review of current knowledge.

Authors:  Patrik Oleksak; Jozef Gonda; Eugenie Nepovimova; Kamil Kuca; Kamil Musilek
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.